Lubris BioPharma Alternatives & Competitors

12 companies similar to Lubris BioPharma

Ampio Pharmaceuticals, Inc.

7 Post-IPO Equity $75.89M

Englewood, United States

Biotechnology Health Care

AEON Biopharma, Inc.

Breaking New Ground

10 Post-IPO Debt $45.00M

Irvine, United States

Biotechnology Health Care +1

Othera Pharmaceuticals

27 Debt Financing $23.62M

Exton, United States

Biotechnology Health Care +1

Promedior

Pioneering advanced therapies to heal fibrotic and inflammatory diseases at their source,...

Venture round $63.00M

Biopharma Biotechnology +2

Rival Readout

Competing with Lubris BioPharma? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Oculis

Visionary Innovation

77 Post-IPO Equity $345.73M

Lausanne, Switzerland

Biotechnology Health Care +1

Gemini Therapeutics

Pioneering precision treatments for genetic eye diseases with a robust pipeline of innovat...

Post-IPO Equity $139.50M

Biopharma Biotechnology +1

Hansa Biopharma

We are dedicated to bring innovative treatments to people living with rare immunological d...

144 Post-IPO Equity $442.20M

Lund, Sweden

Biotechnology Health Care

AM-Pharma

AM-Pharma’s ilofotase alfa is being developed as potential enzyme replacement therapy for...

31 Venture round $207.54M

Utrecht, The Netherlands

Biopharma Biotechnology +2

Artax Biopharma Inc

Developing oral first-in-class Nck blockers for the treatment of T cell mediated autoimmun...

14 Venture round $67.81M

Biopharma Biotechnology +2

Satsuma Pharmaceuticals, Inc.

25 Post-IPO Equity $154.00M

South San Francisco, Unit...

Biotechnology Health Care +2

ESBATech, a Novartis company

13 Series B

Switzerland

Biotechnology Health Care +1

Palatin Technologies

We discover and develop novel therapeutics for patients living with inflammatory and autoi...

50 Post-IPO Equity $133.90M

Biotechnology Health Care +1

Frequently Asked Questions

Companies similar to Lubris BioPharma include Ampio Pharmaceuticals, Inc., AEON Biopharma, Inc., Othera Pharmaceuticals, Promedior, Oculis. They work in Biotechnology and Health Care.

Bounce Watch lists 12 companies that share Lubris BioPharma's industries and are closest to it in business tags, services, target customers, business model and size.

Lµbris BioPharma, **founded in 2011**, is a biopharmaceutical company focusing on **developing recombinant human lubricin** for the treatment of **dry eye, osteoarthritis, and other age & inflammation-related conditions**. This niche area of biotechnology and health care positions the company in a promising market with...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Lubris BioPharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Lubris BioPharma Profile Ampio Pharmaceuticals, Inc. Alternatives AEON Biopharma, Inc. Alternatives Othera Pharmaceuticals Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Lubris BioPharma on 12 Sep 2024. The 11 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.